Sana Biotechnology, Inc.
Fundamentals are temporarily unavailable for SANA.
Market Snapshot
About
Sana Biotechnology is a clinical-stage biotechnology company focused on developing engineered cell therapies. The company works on creating and delivering engineered cells as medicines for patients, with programs targeting blood cancers, solid tumors, autoimmune diseases, and genetic disorders. Sana is developing hypoimmune cell platforms designed to reduce or eliminate the need for immunosuppression.